Author

Ioannis Koutroubakis

ANTIOXIDANT VITAMINS AND ELECTROLYTES INCREASED INTAKE IS ASSOCIATED WITH LOWER DISEASE ACTIVITY AND BETTER QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ANTIOXIDANT VITAMINS AND ELECTROLYTES INCREASED INTAKE IS ASSOCIATED WITH LOWER DISEASE ACTIVITY AND BETTER QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ioannis Koutroubakis  et al.

ASSOCIATION BETWEEN DAILY INTAKE OF ADDED SUGAR AND DISEASE ACTIVITY OR QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ASSOCIATION BETWEEN DAILY INTAKE OF ADDED SUGAR AND DISEASE ACTIVITY OR QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ioannis Koutroubakis  et al.

ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ioannis Koutroubakis  et al.

TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY
TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY

Ioannis Koutroubakis  et al.

TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE
TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE

Ioannis Koutroubakis  et al.

“REAL WORLD” PRELIMINARY DATA ON THE EFFICACY AND SAFETY OF 16-WEEK INDUCTION THERAPY WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS
“REAL WORLD” PRELIMINARY DATA ON THE EFFICACY AND SAFETY OF 16-WEEK INDUCTION THERAPY WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS

Ioannis Koutroubakis  et al.

FACTORS ASSOCIATED WITH TREATMENT PERSISTENCE OF ANTI-TNF AGENTS AS FIRST LINE BIOLOGIC TREATMENT IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASES
FACTORS ASSOCIATED WITH TREATMENT PERSISTENCE OF ANTI-TNF AGENTS AS FIRST LINE BIOLOGIC TREATMENT IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Ioannis Koutroubakis  et al.

UPREGULATED TISSUE FACTOR IN COLONIC MESENCHYMAL CELLS IN ACTIVE ULCERATIVE COLITIS IS ASSOCIATED WITH SEVERE AND RESISTANT TO TREATMENT DISEASE, BUT TOFACITINIB HAS NO EFFECT ON IT
UPREGULATED TISSUE FACTOR IN COLONIC MESENCHYMAL CELLS IN ACTIVE ULCERATIVE COLITIS IS ASSOCIATED WITH SEVERE AND RESISTANT TO TREATMENT DISEASE, BUT TOFACITINIB HAS NO EFFECT ON IT

Ioannis Koutroubakis  et al.

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

Ioannis Koutroubakis  et al.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Ioannis Koutroubakis  et al.

EFFECTS OF COVID-19 ON EMPLOYMENT IN IBD PATIENTS
EFFECTS OF COVID-19 ON EMPLOYMENT IN IBD PATIENTS

Ioannis Koutroubakis  et al.

MENTAL HEALTH, WORK PRESENTEEISM AND EXERCISE IN IBD PATIENTS
MENTAL HEALTH, WORK PRESENTEEISM AND EXERCISE IN IBD PATIENTS

Ioannis Koutroubakis  et al.

PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY
PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY

Ioannis Koutroubakis  et al.

PROPHYLACTIC VERSUS ENDOSCOPY-DRIVEN TREATMENT OF CROHN’S POSTOPERATIVE RECURRENCE: COMPLETED RESULTS OF A RETROSPECTIVE, MULTICENTRIC EUROPEAN STUDY (PORCSE STUDY)
PROPHYLACTIC VERSUS ENDOSCOPY-DRIVEN TREATMENT OF CROHN’S POSTOPERATIVE RECURRENCE: COMPLETED RESULTS OF A RETROSPECTIVE, MULTICENTRIC EUROPEAN STUDY (PORCSE STUDY)

Ioannis Koutroubakis  et al.

THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB
THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB

Ioannis Koutroubakis  et al.

THE NATURAL HISTORY OF COVID-19 IN VACCINATED INFLAMMATORY BOWEL DISEASE PATIENTS
THE NATURAL HISTORY OF COVID-19 IN VACCINATED INFLAMMATORY BOWEL DISEASE PATIENTS

Ioannis Koutroubakis  et al.

EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN´S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN´S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

Ioannis Koutroubakis  et al.

Item 1 - 17 / 17
1